Skip to content
Adam Torkildson – Lifestyle
Author:
Curium
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs
June 18, 2026
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
Curium Announces a Strategic Investment of Over €32 million in Saclay, France
June 1, 2026